Gut microbiota‐derived synbiotic formula (SIM01) as a novel

Microbiota I-Center (MagIC) (香港微生物菌群創新中心) on LinkedIn: #covid #gut # microbiota #microbiome #sim01 #cuhk #cumedicine #covid19

Frontiers Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease

Full article: A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines

Full article: A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines

Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19

Frontiers The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment

Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study - Zhang - 2022 - Journal of Gastroenterology and Hepatology - Wiley Online Library

G-NiiB Immunity+ Formula SIM01

Synbiotics - Food

Multiplex Assays for COVID-19 (SARS-CoV-2) Research Applications

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial - The Lancet Infectious Diseases